Auris Achieves High Valuation

Jul 17 2017

PitchBook

Auris joined the unicorn ranks in 2017 for reaching billion-dollar valuation. According to the article, 53 venture capital-backed companies reached billion-dollar valuations last year. Auris is the only company listed for robotics, medical robotics or endoscopy robotics.

Excerpt from article:
"We are keeping a close eye on startups on the verge of reaching a billion-dollar valuation..."

See Where Auris is on the List...
Back to all News

Complications from bronchoscopy are rare and most often minor, but if they occur, may include breathing difficulty, vocal cord spasm, hoarseness, slight fever, vomiting, dizziness, bronchial spasm, infection, low blood oxygen, bleeding from biopsied site, or an allergic reaction to medications. Only rarely do patients experience other more serious complications (for example, collapsed lung, respiratory failure, heart attack and/or cardiac arrhythmia).